GlaxoSmithKline has decided to stop paying doctors to promote its products, which was usually done by the doctors speaking at healthcare conferences. The company will also stop tying compensation of sales representatives to the number of prescriptions doctors write, i.e., no more sales commissions.
I wonder whether these changes are due to the Affordable Care Act, which will require disclosure of these types of payments.
No comments:
Post a Comment